⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Kolon Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Kolon Group
↗Gwacheon, South Korea
Kolon Group is a prominent South Korean conglomerate founded in 1957, originally as Korea Nylon Inc. The group operates through a diverse portfolio of subsidiaries spanning key materials, chemicals, fashion, construction, energy, and bio-healthcare.
In the life sciences sector, the group operates through specialized entities such as Kolon Life Science, Kolon Pharma, and Kolon TissueGene. These divisions focus on advanced cell and gene therapies, pharmaceutical manufacturing, and clinical translational research, with a particular emphasis on orthopedic and degenerative disorders.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Conglomerate
Sub-Industry:Chemicals, Materials, and Biopharmaceuticals
SIZE & FINANCIALS
Employees:1000-5000
Revenue:$3B-$4B
Founded:1957
Ownership:public
Status:operating
STOCK
Exchange:KRX
Ticker:002020
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3 (TG-C)
Modalities:Cell therapy, Gene therapy, Small molecule
Active Trials:0
Trial Phases:Phase 1: 1 | Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Kolon Industries, Kolon Life Science, Kolon TissueGene, Kolon Pharma, Kolon Global, Kolon SpaceWorks
Key Partnerships:Various global pharmaceutical firms for technology transfer and clinical collaboration.
COMPETITION
Position:Challenger
Competitors:LG Chem, Hanmi Pharmaceutical, Samsung Biologics
LEADERSHIP
Key Executives:
Jeon Seng-ho - CEO, Kolon TissueGene
Board Members:Jan Van Acker, Robert Yuen Lee Ang
LINKS
Website:kolon.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Kolon Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.